Back to search
Low Tension Glaucoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Low Tension Glaucoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Low Tension Glaucoma trials you may qualify forGlaucoma is a progressive optic neuropathy with retinal ganglion cell loss which leads to visual field loss. Open-angle glaucoma is the most common form of glau…
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
The objective of this study is to evaluate the safety and effectiveness of Direct Selective Laser Trabeculoplasty (DSLT) in ethnic Chinese participants with Pri…
Glaucoma is characterized by a progressive loss of retinal ganglion cells (RGCs) leading to optic nerve head (ONH) damage and associated visual field defects. T…
To assure the quality of follow-up and treatment, data of glaucoma patients are stored and evaluated after anonymisation.
The purpose of this study is to assess whether deep sclerectomy is as effective in lowering intraocular pressure (IOP) as trabeculectomy in patients with normal…
Qlaris' Phase 2 clinical trial investigating the safety, tolerability, and ocular hypotensive efficacy of QLS-111 in normal tension glaucoma patients.
The goal of this clinical trial is to learn if a new contact lens device can record patterns in eye pressure for 24 hours in adults with glaucoma and in healthy…